The application of risk models based on machine learning to predict endometriosis-associated ovarian cancer in patients with endometriosis

被引:14
|
作者
Chao, Xiaopei [1 ,2 ]
Wang, Shu [1 ,2 ]
Lang, Jinghe [1 ,2 ]
Leng, Jinhua [1 ,2 ]
Fan, Qingbo [1 ,2 ]
机构
[1] Chinese Acad Med Sci CAMS & Peking Union Med Coll, Dept Obstet & Gynecol, Peking Union Med Coll Hosp PUMCH, Beijing, Peoples R China
[2] Natl Clin Res Ctr Obstet & Gynecol Dis, Beijing, Peoples R China
基金
国家重点研发计划;
关键词
endometriosis; machine learning; malignant transformation; ovarian cancer; risk model;
D O I
10.1111/aogs.14462
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Introduction There is currently no satisfactory model for predicting malignant transformation of endometriosis. The aim of this study was to construct and evaluate a risk model incorporating noninvasive clinical parameters to predict endometriosis-associated ovarian cancer (EAOC) in patients with endometriosis. Material and Methods We enrolled 6809 patients with endometriosis confirmed by pathology, and randomly allocated them to training (n = 4766) and testing cohorts (n = 2043). The proportion of patients with EAOC in each cohort was similar. We extracted a total of 94 demographic and clinicopathologic features from the medical records using natural language processing. We used a machine learning method - gradient-boosting decision tree - to construct a predictive model for EAOC and to evaluate the accuracy of the model. We also constructed a multivariate logistic regression model inclusive of the EAOC-associated risk factors using a back stepwise procedure. Then we compared the performance of the two risk-predicting models using DeLong's test. Results The occurrence of EAOC was 1.84% in this study. The logistic regression model comprised 10 selected features and demonstrated good discrimination in the testing cohort, with an area under the curve (AUC) of 0.891 (95% confidence interval [CI] 0.821-0.960), sensitivity of 88.9%, and specificity of 76.7%. The risk model based on machine learning had an AUC of 0.942 (95% CI 0.914-0.969), sensitivity of 86.8%, and specificity of 86.7%. The machine learning-based risk model performed better than the logistic regression model in DeLong's test (p = 0.036). Furthermore, in a prospective dataset, the machine learning-based risk model had an AUC of 0.8758, a sensitivity of 94.4%, and a specificity of 73.8%. Conclusions The machine learning-based risk model was constructed to predict EAOC and had high sensitivity and specificity. This model could be of considerable use in helping reduce medical costs and designing follow-up schedules.
引用
收藏
页码:1440 / 1449
页数:10
相关论文
共 50 条
  • [21] The molecular signature of endometriosis-associated endometrioid ovarian cancer differs significantly from endometriosis-independent endometrioid ovarian cancer
    Banz, Constanze
    Ungethuem, Ute
    Kuban, Ralf-Juergen
    Diedrich, Klaus
    Lengyel, Ernst
    Hornung, Daniela
    FERTILITY AND STERILITY, 2010, 94 (04) : 1212 - 1217
  • [22] Differentiation between endometriosis-associated ovarian cancers and non- endometriosis-associated ovarian cancers based on magnetic resonance imaging
    Zhang, Ximing
    Li, Min
    Tang, Znuopeng
    Li, Xinyi
    Song, Ting
    BRITISH JOURNAL OF RADIOLOGY, 2021, 94 (1125)
  • [23] Prognostic importance of atypical endometriosis with architectural hyperplasia versus cytologic atypia in endometriosis-associated ovarian cancer
    Niguez Sevilla, Isabel
    Machado Linde, Francisco
    Marin Sanchez, Maria del Pilar
    Jesus Arense, Julian
    Torroba, Amparo
    Nieto Diaz, Anibal
    Sanchez Ferrer, Maria Luisa
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2019, 30 (04)
  • [24] Evaluation of Immune Infiltrates in Ovarian Endometriosis and Endometriosis-Associated Ovarian Cancer: Relationship with Histological and Clinical Features
    Spagnolo, Emanuela
    Martinez, Alejandra
    Mascaros-Martinez, Andrea
    Mari-Alexandre, Josep
    Carbonell, Maria
    Gonzalez-Canto, Eva
    Pena-Burgos, Eva Manuela
    Mc Cormack, Barbara Andrea
    Tomas-Perez, Sarai
    Gilabert-Estelles, Juan
    Lopez-Carrasco, Ana
    Hidalgo, Paula
    Angeles, Martina Aida
    Redondo, Andres
    Gallego, Alejandro
    Hernandez, Alicia
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (15)
  • [25] Targeted next-generation sequencing for molecular diagnosis of endometriosis-associated ovarian cancer
    Tze-Kiong Er
    Yu-Fa Su
    Chun-Chieh Wu
    Chih-Chieh Chen
    Jing Wang
    Tsung-Hua Hsieh
    Marta Herreros-Villanueva
    Wan-Tzu Chen
    Yi-Ting Chen
    Ta-Chih Liu
    Hung-Sheng Chen
    Eing-Mei Tsai
    Journal of Molecular Medicine, 2016, 94 : 835 - 847
  • [26] Targeted next-generation sequencing for molecular diagnosis of endometriosis-associated ovarian cancer
    Er, Tze-Kiong
    Su, Yu-Fa
    Wu, Chun-Chieh
    Chen, Chih-Chieh
    Wang, Jing
    Hsieh, Tsung-Hua
    Herreros-Villanueva, Marta
    Chen, Wan-Tzu
    Chen, Yi-Ting
    Liu, Ta-Chih
    Chen, Hung-Sheng
    Tsai, Eing-Mei
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2016, 94 (07): : 835 - 847
  • [27] Chronic inflammation in endometriosis and endometriosis-associated ovarian cancer: New roles for the "old" complement pathway
    Edwards, Robert P.
    Huang, Xin
    Vlad, Anda M.
    ONCOIMMUNOLOGY, 2015, 4 (05):
  • [28] Clinical significance of initial symptoms in endometriosis-associated ovarian cancer
    Ono, Maaya
    Fukuda, Mayu
    Yamanoi, Koji
    Sunada, Masumi
    Kitamura, Sachiko
    Taki, Mana
    Horie, Akihito
    Yamaguchi, Ken
    Hamanishi, Junzo
    Mandai, Masaki
    TURKISH JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2024, 21 (01) : 28 - 36
  • [29] Identification and Validation of Prognostic Markers for Endometriosis-Associated Ovarian Cancer
    Yang, Huilin
    Deng, Yue
    Dong, Ying
    Ma, Yiqun
    Yang, Lihua
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2024, 21 (10): : 1903 - 1914
  • [30] Gene Discovery through Germline Whole Exome Sequencing in Patients with Endometriosis-Associated Ovarian Cancer
    Dow, Eryn
    Campbell, Ian
    James, Paul
    Antill, Yoland
    Subramanian, Deepak
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 114 - 115